+

US5443819A - Composition and method of enhancing sun tanning - Google Patents

Composition and method of enhancing sun tanning Download PDF

Info

Publication number
US5443819A
US5443819A US08/150,015 US15001593A US5443819A US 5443819 A US5443819 A US 5443819A US 15001593 A US15001593 A US 15001593A US 5443819 A US5443819 A US 5443819A
Authority
US
United States
Prior art keywords
pseudocatalase
composition
skin
complex
bicarbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/150,015
Inventor
John M. Wood
Karin U. Schallreuter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Laboratories Inc
Original Assignee
Stiefel Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Laboratories Inc filed Critical Stiefel Laboratories Inc
Assigned to STIEFEL LABORATORIES, INC. reassignment STIEFEL LABORATORIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SCHALLREUTER, KARIN UTA, WOOD, JOHN MARTIN
Application granted granted Critical
Publication of US5443819A publication Critical patent/US5443819A/en
Assigned to DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT reassignment DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT FIRST LIEN PATENT SECURITY AGREEMENT Assignors: CONNETICS CORPORATION, STIEFEL LABORATORIES, INC.
Assigned to DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT reassignment DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT SECOND LIEN PATENT SECURITY AGREEMENT Assignors: CONNETICS CORPORATION, STIEFEL LABORATORIES, INC.
Assigned to DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT reassignment DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT FIRST LIEN PATENT SECURITY AGREEMENT Assignors: CONNETICS CORPORATION, STIEFEL LABORATORIES, INC.
Assigned to DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT reassignment DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT SECOND LIEN PATENT SECURITY AGREEMENT Assignors: CONNETICS CORPORATION, STIEFEL LABORATORIES, INC.
Assigned to CONNETICS CORPORATION, STIEFEL LABORATORIES, INC. reassignment CONNETICS CORPORATION RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT Assignors: DEUTSCHE BANK TRUST COMPANY AMERICAS
Assigned to STIEFEL LABORATORIES, INC., CONNETICS CORPORATION reassignment STIEFEL LABORATORIES, INC. RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT Assignors: DEUTSCHE BANK TRUST COMPANY AMERICAS
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Definitions

  • the present invention relates to the enhancement of sun tanning and has particular, but not exclusive, application to the sun tanning of fair skin (ie. Types I and II skins).
  • tanning can be enhanced by topical application of manganese (II) bicarbonate or other pseudocatalases.
  • pseudocatalase we mean a plasma membrane permeable physiologically acceptable compound which catalyzes the dismutation of H 2 O 2 in vivo in analogous manner to catalase.
  • a pseudocatalase in the manufacture of a topical composition for the enhancement of tanning of skin, especially fair skin, on exposure to sunlight or UVB light.
  • the invention provides a topical sunscreen composition
  • a topical sunscreen composition comprising a pseudocatalase, a sunscreen agent and a physiologically acceptable topical vehicle therefor.
  • the invention provides a pseudocatalase for use in the enhancement of tanning of skin, especially fair skin, on exposure to sunlight or UVB light.
  • the invention provides a method of enhancing tanning of skin, especially fair skin, which comprises applying to the skin an effective amount of a pseudocatalase.
  • the invention provides use of a pseudocatalase to enhance tanning of skin on exposure to sunlight or UVB light.
  • the pseudocatalase can be any physiologically acceptable compound which catalyzes the dismutation of hydrogen peroxide.
  • Some compounds such as Mn(II) bicarbonate are already known to be pseudocatalases and others can be determined by simple screening tests.
  • the pseudocatalase is formulated in a topical vehicle for use.
  • the vehicle comprises a hydrophilic cream to which an aqueous solution or suspension of the pseudocatalase is added to form a cream or lotion.
  • the vehicle can be a bath oil although any other compatible topical vehicle can be used to provide a topical composition.
  • the composition will contain a sunscreen agent and other components such as emollients, perfumes etc conventionally used in sunscreen preparations.
  • the composition can contain calcium ions, suitably added as calcium chloride, usually in a concentration of 5 to 20 millimolar.
  • any conventional sunscreen agent such as Parsol MCX, or other component can be used.
  • Manganous chloride (380 mg) was added to a solution of sodium bicarbonate (2.3 g) in purified water (3.0 ml) at ambient temperature. The mixture was allowed to stand until the evolution of gas had ceased. The resultant pinkish brown liquid was mixed with a hydrophilic cream (Neribase) to provide a white cream.
  • Neribase is a cream vehicle containing Macrogol stearate 2000; stearic alcohol; liquid paraffin; white soft paraffin; polyacrylic acid; sodium hydroxide; disodium EDTA (i.e. ethylenediaminetetraacetic acid disodium salt); methyl and propyl Paraben (i.e. 4-hydroxybenzoic acid methyl and propyl esters); and water.
  • disodium EDTA i.e. ethylenediaminetetraacetic acid disodium salt
  • methyl and propyl Paraben i.e. 4-hydroxybenzoic acid methyl and propyl esters
  • the cream was applied to test skin areas of healthy volunteers having skin type II or III and, after a period of 20, 45 or 60 minutes, the treated skin exposed to UVB light for 10 to 20 seconds.
  • the UVB source was a Saalmann UV-Test machine and the doses were 0.06, 0.05, 0.04, 0.03, 0.02 mJ/cm 2 (10 seconds) and 0.18, 0.15, 0.12, 0.09, 0.06 mJ/cm 2 (30 seconds).
  • the degree of erythema/tanning of the treated area and untreated area was determined by observation after 24 and 72 hours post-irradiation.
  • Example 1 The test of Example 1 was repeated using creams to which calcium chloride had been added to provide 5 millimolar or 10 mmole calcium ion content. The results are set forth in Tables II and III below.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Reinforced Plastic Materials (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

PCT No. PCT/GB92/00877 Sec. 371 Date Nov. 15, 1993 Sec. 102(e) Date Nov. 15, 1993 PCT Filed May 15, 1992 PCT Pub. No. WO92/20321 PCT Pub. Date Nov. 26, 1992.The present invention relates to the enhancement of suntanning following exposure to sunlight or other source of UV light by topically applying pseudocatalase compounds.

Description

This application of the notional stage of PCT/GB0-877 filed May 15, 1992.
The present invention relates to the enhancement of sun tanning and has particular, but not exclusive, application to the sun tanning of fair skin (ie. Types I and II skins).
The extent of sun tanning following exposure to sunlight or other source of UV light depends upon the type of skin. Those with fair skin (ie. Types I and II) do not readily tan and are much more liable to sunburn than those with dark skin (ie. Types IV and V). Existing sunscreen preparations protect against sunburn but do not enhance tanning compared with the unprotected skin.
It has now surprisingly been found that tanning can be enhanced by topical application of manganese (II) bicarbonate or other pseudocatalases.
We have disclosed in a co-pending Patent Application of the same priority and filing dates and corresponding to UK Patent Application No. 9110652 that pseudocatalase can be used topically to treat vitiligo.
By pseudocatalase, we mean a plasma membrane permeable physiologically acceptable compound which catalyzes the dismutation of H2 O2 in vivo in analogous manner to catalase.
Exposure of the skin to UVB radiation generates superoxide anion radicals which is a preferred substrate for human tyrosinase (40 times better than oxygen) thereby promoting melanin formation. However, the superoxide anion radicals are dismutated into dioxygen and peroxide ion causing an undesirable increase in hydroxyl ion concentration unless catalase or some other competing mechanism removes peroxide ion. Thus, the presence of a pseudocatalase is believed to allow sufficient UVB exposure for superoxide anion radical formation to promote pigmentation in catalase deficient areas without burning or other cell damage.
According to a first aspect of the present invention, there is provided the use of a pseudocatalase in the manufacture of a topical composition for the enhancement of tanning of skin, especially fair skin, on exposure to sunlight or UVB light.
In a second aspect, the invention provides a topical sunscreen composition comprising a pseudocatalase, a sunscreen agent and a physiologically acceptable topical vehicle therefor.
In a third aspect, the invention provides a pseudocatalase for use in the enhancement of tanning of skin, especially fair skin, on exposure to sunlight or UVB light.
In a fourth aspect, the invention provides a method of enhancing tanning of skin, especially fair skin, which comprises applying to the skin an effective amount of a pseudocatalase.
In a fifth aspect, the invention provides use of a pseudocatalase to enhance tanning of skin on exposure to sunlight or UVB light.
The pseudocatalase can be any physiologically acceptable compound which catalyzes the dismutation of hydrogen peroxide. Some compounds such as Mn(II) bicarbonate are already known to be pseudocatalases and others can be determined by simple screening tests.
The presently preferred pseudocatalases are transition metal co-ordination complexes in which the inductive effect of the electron acceptor ligand enhances the redox effect of the metal on hydrogen peroxide dismutation. Usually, the metal will be Cu(I), Fe(II) or, especially Mn(II) and the ligand will be bicarbonate. It is especially preferred that the pseudocatalase is Mn(II) bicarbonate complex. Said complex readily can be prepared by contacting manganous chloride with excess bicarbonate in aqueous solution.
The pseudocatalase is formulated in a topical vehicle for use. Conveniently, the vehicle comprises a hydrophilic cream to which an aqueous solution or suspension of the pseudocatalase is added to form a cream or lotion. Alternatively, the vehicle can be a bath oil although any other compatible topical vehicle can be used to provide a topical composition.
Usually, the composition will contain a sunscreen agent and other components such as emollients, perfumes etc conventionally used in sunscreen preparations. In particular, the composition can contain calcium ions, suitably added as calcium chloride, usually in a concentration of 5 to 20 millimolar. Subject to compatibility with the pseudocatalase and superoxide anion, any conventional sunscreen agent, such as Parsol MCX, or other component can be used.
The invention is illustrated in the following non-limiting Examples.
EXAMPLE 1
Manganous chloride (380 mg) was added to a solution of sodium bicarbonate (2.3 g) in purified water (3.0 ml) at ambient temperature. The mixture was allowed to stand until the evolution of gas had ceased. The resultant pinkish brown liquid was mixed with a hydrophilic cream (Neribase) to provide a white cream.
Neribase is a cream vehicle containing Macrogol stearate 2000; stearic alcohol; liquid paraffin; white soft paraffin; polyacrylic acid; sodium hydroxide; disodium EDTA (i.e. ethylenediaminetetraacetic acid disodium salt); methyl and propyl Paraben (i.e. 4-hydroxybenzoic acid methyl and propyl esters); and water.
The cream was applied to test skin areas of healthy volunteers having skin type II or III and, after a period of 20, 45 or 60 minutes, the treated skin exposed to UVB light for 10 to 20 seconds. The UVB source was a Saalmann UV-Test machine and the doses were 0.06, 0.05, 0.04, 0.03, 0.02 mJ/cm2 (10 seconds) and 0.18, 0.15, 0.12, 0.09, 0.06 mJ/cm2 (30 seconds). The degree of erythema/tanning of the treated area and untreated area was determined by observation after 24 and 72 hours post-irradiation.
The results are set forth in Table I below. The erythema increase is indicated on the scale +, ++ and +++ with ++ and +++ presenting a darker tan.
              TABLE I                                                     
______________________________________                                    
Sex/   Skin    T.sub.1 T.sub.2                                            
                            24 h treated/                                 
                                     72 h treated/                        
age    type    min     sec  control side                                  
                                     control side                         
______________________________________                                    
M/27   III     20      10   no difference                                 
                                     no difference                        
F/22   III     20      10   +++/+    ++/+                                 
F/25   III     20      10   +++/++   ++/+                                 
F/23   III     20      10   +++/++   +++/+                                
M/30   III     20      10   +++/++   ++/+                                 
M/23   III     20      10   ++/+++   no difference                        
M/24   III     20      10   +/++     no difference                        
F/25   II      20      10   +++/++   ++/+                                 
F/28   II      20      10   +++/++   ++/++                                
______________________________________                                    
 +-+++: grade of erythema/tanning                                         
 T.sub.1 = time between application and UVB irradiation                   
 T.sub.2 = time of UVB irradiation
EXAMPLE 2
The test of Example 1 was repeated using creams to which calcium chloride had been added to provide 5 millimolar or 10 mmole calcium ion content. The results are set forth in Tables II and III below.
              TABLE II                                                    
______________________________________                                    
(5 mmol Ca.sup.2+)                                                        
Sex/   Skin    T.sub.1 T.sub.2                                            
                            24 h treated/                                 
                                     72 h treated/                        
age    type    min     sec  control side                                  
                                     control side                         
______________________________________                                    
F/26   III     20      10   +++/++   ++/+                                 
M/52   III     20      10   +++/++   ++/+                                 
F/21   III     20      10   ++/+++   +/++                                 
F/22   III     20      10   ++/+++   +/++                                 
M/27   III     40      10   +/++     +/++                                 
F/25   III     20      30   +++/++   ++/++                                
F/27   III     20      30   no difference                                 
                                     +/++                                 
F/28   III     60      30   ++/+++   +/++                                 
F/19   II      20      10   ++/+++   +/+++                                
M/32   II      20      10   +/++     +/++                                 
F/43   II      45      10   +++/++   +++/ ++                              
M/21   II      45      10   ++/+     ++/+                                 
M/27   II      60      10   no difference                                 
                                     no difference                        
M/30   II      20      30   +++/++   +++/++                               
M/33   II      20      30   +++/++   ++/+                                 
______________________________________                                    
 +-+++: grade of erythema/tanning                                         
 T.sub.1 = time between application and UVB irradiation                   
 T.sub.2 = time of UVB irradiation                                        

              TABLE III                                                   
______________________________________                                    
(10 mmol Ca.sup.2+)                                                       
Sex/   Skin    T.sub.1 T.sub.2                                            
                            24 h treated/                                 
                                     72 h treated/                        
age    type    min     sec  control side                                  
                                     control side                         
______________________________________                                    
F/27   III     20      10   +/++     +/++                                 
M/50   III     20      10   +++/++   ++/+                                 
F/21   III     20      10   +++/++   ++/+                                 
F/22   III     20      10   no difference                                 
                                     no difference                        
F/23   II      20      10   no difference                                 
                                     no difference                        
F/49   II      20      10   +/++     no difference                        
M/25   II      20      10   ++/+     +++/++                               
F/47   II      45      10   +++/++   +++/++                               
M/24   II      45      10   ++/+     ++/+                                 
M/25   II      45      10   ++/+++   +/++                                 
______________________________________                                    
 +-+++: grade of erythema/tanning                                         
 T.sub.1 = time between application and UVB irradiation                   
 T.sub.2 = time of UVB irradiation

Claims (15)

We claim:
1. A topical composition for enhancing tanning of the skin, comprising: an effective amount of a pseudocatalase; an effective amount of a sunscreen agent; and a physiologically acceptable topical vehicle, wherein the pseudocatalase is a transition metal bicarbonate complex.
2. The composition according to claim 1, wherein the composition is free of calcium ions.
3. The composition according to claim 1, wherein the composition contains 5 to 20 millimolar calcium ions.
4. The composition according to claim 1, wherein the transition metal is selected from the group consisting of Cu(I), Fe(II), and Mn(II).
5. The composition according to claim 5, wherein the complex is a Mn(II)-bicarbonate complex.
6. The composition according to claim 5, wherein the Mn(II)-bicarbonate complex has been obtained by contacting manganous chloride with excess sodium bicarbonate in aqueous solution.
7. A method of enhancing tanning of skin which comprises applying to the skin an effective amount of a pseudocatalase, wherein the pseudocatalase is a transition metal bicarbonate complex.
8. The method according to claim 7, which further comprises exposing pseudocatalase-treated skin to sunlight or UVB light.
9. The method according to claim 7, wherein the pseudocatalase is admixed with a physiologically acceptable topical vehicle.
10. The method according to claim 7 wherein the transition metal is selected from the group consisting of Cu(I), Fe(II), and Mn(II).
11. The method according to claim 10 wherein the complex is Mn(II)-bicarbonate complex.
12. The method according to claim 11 wherein the Mn(II) bicarbonate complex is obtained from contacting manganous chloride with excess sodium bicarbonate in aqueous solution.
13. The method according to claim 7 wherein the pseudocatalase is admixed with an effective amount of a sunscreen agent.
14. The method according to claim 7 wherein the pseudocatalase is applied as a composition free of calcium ions.
15. The method according to claim 7 wherein the pseudocatalase is applied as a composition containing 5 to 20 millimolar calcium ions.
US08/150,015 1991-05-15 1992-05-15 Composition and method of enhancing sun tanning Expired - Fee Related US5443819A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9110651 1991-05-15
GB919110651A GB9110651D0 (en) 1991-05-15 1991-05-15 Composition and method of enhancing sun tanning
PCT/GB1992/000877 WO1992020321A1 (en) 1991-05-15 1992-05-15 Composition and method of enhancing sun tanning

Publications (1)

Publication Number Publication Date
US5443819A true US5443819A (en) 1995-08-22

Family

ID=10695130

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/150,015 Expired - Fee Related US5443819A (en) 1991-05-15 1992-05-15 Composition and method of enhancing sun tanning

Country Status (18)

Country Link
US (1) US5443819A (en)
EP (1) EP0584178B1 (en)
JP (1) JPH06510274A (en)
AT (1) ATE141785T1 (en)
AU (1) AU650343B2 (en)
CA (1) CA2102515A1 (en)
DE (1) DE69213231T2 (en)
ES (1) ES2091467T3 (en)
GB (1) GB9110651D0 (en)
GR (1) GR3021364T3 (en)
HK (1) HK198396A (en)
IE (1) IE69260B1 (en)
IL (1) IL101873A (en)
MY (1) MY108163A (en)
NZ (1) NZ242749A (en)
TW (1) TW201693B (en)
WO (1) WO1992020321A1 (en)
ZA (1) ZA923560B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839449A1 (en) * 2002-05-13 2003-11-14 Oreal Skin desquamation promoters and/or epidermal renewal stimulants, useful e.g. for combating skin aging symptoms or treating psoriasis, comprising metal complexes having hydrolytic action
US20030224028A1 (en) * 2002-05-13 2003-12-04 Societe L'oreal S.A. Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal
US20070038269A1 (en) * 2003-02-26 2007-02-15 Photo Therapeutics Ltd. Therapeutic method and apparatus

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2307175A (en) * 1995-11-14 1997-05-21 Steifel Lab Inc Topical composition comprising a transition metal and bicarbonate ions, particularly for the promotion of pigmentation
WO2002030375A1 (en) 2000-10-09 2002-04-18 L"Oreal Dyeing composition, method for obtaining same and use for colouring the skin and/or keratinous fibres
FR2814945B1 (en) * 2000-10-09 2003-02-14 Oreal CANITIY TREATMENT PROCESS
US20040148712A1 (en) 2002-11-29 2004-08-05 Francis Pruche Composition for coloring a keratin material, comprising at least two components, and coloring processes
EP2168570B1 (en) 2008-09-30 2013-12-25 Symrise AG Extracts of isochrysis sp.
EP3348255B1 (en) 2008-12-05 2021-11-10 Symrise AG Extracts of tetraselmis sp. for cosmetic and therapeutic purposes
KR101676375B1 (en) 2009-04-09 2016-11-15 시므라이즈 아게 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
US20160008297A1 (en) 2012-08-23 2016-01-14 B.R.A.I.N. Biotechnology Research And Information Network Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
ES2701758T3 (en) 2013-02-27 2019-02-25 Symrise Ag Ginger extract for the protection of stem cells
ES2647784T3 (en) 2013-03-08 2017-12-26 Symrise Ag Cosmetic compositions
EP2842607B1 (en) 2013-09-02 2018-05-30 Symrise AG A skin and/or hair whitening mixture
EP3721944A1 (en) 2013-09-22 2020-10-14 Cutech S.R.L. Extracts of halimione portulacoides and their application
EP2859883B1 (en) 2013-10-13 2019-05-15 Symrise AG Active mixtures comprising acylated oligopeptides and troxerutin
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
EP3062766A1 (en) 2013-10-29 2016-09-07 L'Oreal, S.A. Use of mono ornithine ketoglutarate (mokg)
EP3443950A1 (en) 2014-07-30 2019-02-20 Symrise AG A fragrance composition
EP3023090B1 (en) 2014-11-21 2019-08-07 Symrise AG Compositions
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol
EP3081207B1 (en) 2015-04-16 2022-09-21 Symrise AG Use of a liposome composition
WO2016174011A1 (en) 2015-04-28 2016-11-03 Cutech Srl Compositions comprising valerian extracts
EP3097905B1 (en) 2015-05-28 2020-11-04 Symrise AG Cosmetic compositions
EP3108941B1 (en) 2015-06-23 2018-05-09 Symrise AG Compositions comprising polyalkylene glycol derivatives
WO2017041834A1 (en) 2015-09-08 2017-03-16 Symrise Ag Fragrance mixtures
CN108366932B (en) 2015-10-28 2022-03-15 西姆莱斯股份公司 Method for inhibiting or masking fishy smell
JP6784760B2 (en) 2015-11-15 2020-11-11 シムライズ アーゲー Reduction of skin sting
WO2017097434A1 (en) 2015-12-06 2017-06-15 Symrise Ag A fragrance composition
US11918679B2 (en) 2016-03-30 2024-03-05 Symrise Ag Active mixure
CN109475490B (en) 2016-05-23 2021-11-30 西姆莱斯股份公司 Hair care composition containing wheat bran extract
WO2018036625A1 (en) 2016-08-20 2018-03-01 Symrise Ag A preservative mixture
JP7441042B2 (en) 2016-12-02 2024-02-29 シムライズ アーゲー cosmetic blend
IT201700090929A1 (en) 2017-08-07 2019-02-07 Cutech S R L Cosmetic and medical uses of extracts of Coprinus comatus fungus for the regulation of pilo sebaceous unity.
WO2019029808A1 (en) 2017-08-09 2019-02-14 Symrise Ag 1,2-alkanediols and a process for their production
DE202017007679U1 (en) 2017-08-09 2024-03-15 Symrise Ag 1,2-Alkanediols
CN111032015A (en) 2017-08-23 2020-04-17 西姆莱斯有限公司 New use of extract of Isochrysis galbana
WO2019037844A1 (en) 2017-08-23 2019-02-28 Symrise Ag Novel compositions of natural butters and uses thereof
JP7104149B2 (en) 2017-10-10 2022-07-20 シムライズ アーゲー Use of compositions containing benzoic acid or chlorofluorocarbon derivatives and said derivatives for emulsion and foam stability
CN111936120A (en) 2018-03-08 2020-11-13 西姆莱斯股份公司 Mixtures containing protein extracts for the treatment of human skin and/or hair
WO2018154145A2 (en) 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment
EP3849505A1 (en) 2018-09-14 2021-07-21 Symrise AG A hair care composition
CN112912051A (en) 2018-09-20 2021-06-04 西姆莱斯股份公司 Composition comprising 1, 2-pentanediol
WO2020088778A1 (en) 2018-11-02 2020-05-07 Symrise Ag A liquid and transparent blend of uv filters
WO2020094244A1 (en) 2018-11-08 2020-05-14 Symrise Ag An antimicrobial surfactant based composition
US20220168198A1 (en) 2019-01-17 2022-06-02 Symrise Ag An antimicrobial mixture
EP3938054A1 (en) 2019-03-11 2022-01-19 Symrise AG A method for improving the performance of a fragrance or a fragrance mixture
BR112021017339B1 (en) 2019-03-12 2024-01-30 Symrise Ag ANTIMICROBIAL MIXTURE, COSMETIC COMPOSITION, PERSONAL CARE COMPOSITION, PHARMACEUTICAL COMPOSITION, DETERGENT COMPOSITION OR FOOD COMPOSITION, AND METHOD OF PREVENTION OR TREATMENT THEREOF
CN113766911A (en) 2019-03-22 2021-12-07 西姆莱斯股份公司 Plant peptides and uses thereof (II)
WO2020192865A1 (en) 2019-03-22 2020-10-01 Symrise Ag Plant peptides and their applications
EP3982910A1 (en) 2019-06-13 2022-04-20 Symrise AG A cooling preparation
AU2019453263A1 (en) 2019-07-02 2022-01-06 Symrise Ag Blend of beeswax and a lactylate ester
CN114364773A (en) 2019-09-04 2022-04-15 西姆莱斯股份公司 Aromatic oil mixture
CN114727914A (en) 2019-10-16 2022-07-08 西姆莱斯股份公司 Product for the indirect transfer of a cosmetic active to the skin
WO2021228352A1 (en) 2020-05-11 2021-11-18 Symrise Ag A fragrance composition
EP4096618B1 (en) 2020-12-09 2025-01-29 Symrise AG A mixture comprising 1,2-alkanediols
WO2022128164A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
WO2022128390A1 (en) 2020-12-14 2022-06-23 Symrise Ag Cosmetic and/or pharmaceutical compositions containing cannabinoids
WO2022129101A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
WO2022214187A1 (en) 2021-04-08 2022-10-13 Symrise Ag An o/w emulsion base and emulsions comprising the same
EP4322911A1 (en) 2021-04-13 2024-02-21 Symrise AG A fragrance mixture containing isocitronellol
EP4326251A1 (en) 2021-04-19 2024-02-28 Symrise AG Compositions comprising cannabidiol and, optionally, bisabolol
EP4083050A1 (en) 2021-05-01 2022-11-02 Analyticon Discovery GmbH Microbial glycolipids
EP4134426A1 (en) 2021-08-13 2023-02-15 Symrise AG Novel bacterial ferment of lactobacillus species
CN117813077A (en) 2021-08-16 2024-04-02 西姆莱斯股份公司 Composition and method for producing the same
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents
EP4433565A1 (en) 2021-11-17 2024-09-25 Symrise AG Fragrances and fragrance mixtures
CN118829416A (en) 2022-02-02 2024-10-22 西姆莱斯股份公司 Composition (III)
EP4473079A1 (en) 2022-02-04 2024-12-11 Symrise AG A fragrance mixture
WO2023160805A1 (en) 2022-02-25 2023-08-31 Symrise Ag Fragrances with methoxy acetate structure
EP4489723A1 (en) 2022-03-11 2025-01-15 Symrise AG Hair care composition
EP4245291A1 (en) 2022-03-17 2023-09-20 Symrise AG Additive for sunscreens
EP4245292A1 (en) 2022-03-17 2023-09-20 Symrise AG Additive for sunscreens
WO2023175129A1 (en) 2022-03-17 2023-09-21 Symrise Ag Additive for sunscreens
CN119317695A (en) 2022-05-04 2025-01-14 西姆莱斯股份公司 Spice mixture (V)
WO2023232243A1 (en) 2022-06-01 2023-12-07 Symrise Ag A fragrance mixture (v)
CN119255980A (en) 2022-06-01 2025-01-03 西姆莱斯股份公司 Cyclopropyl fragrances
WO2023232242A1 (en) 2022-06-01 2023-12-07 Symrise Ag Fragrance mixture
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide
WO2024027922A1 (en) 2022-08-05 2024-02-08 Symrise Ag A fragrance mixture (ii)
WO2024037712A1 (en) 2022-08-17 2024-02-22 Symrise Ag 1-cyclooctylpropan-2-one as a fragrance
EP4331564A1 (en) 2022-08-29 2024-03-06 Analyticon Discovery GmbH Antioxidant composition comprising 5-deoxyflavonoids
WO2024051922A1 (en) 2022-09-06 2024-03-14 Symrise Ag A fragrance mixture (iii)
WO2024061476A1 (en) 2022-09-19 2024-03-28 Symrise Ag A method for preventing, mitigating and/or treating ptgs2-induced skin disorders and related dysfunctions
WO2024078679A1 (en) 2022-10-10 2024-04-18 Symrise Ag A fragrance mixture (vi)
WO2024104546A1 (en) 2022-11-14 2024-05-23 Symrise Ag A blend of emollients
WO2024110023A1 (en) 2022-11-23 2024-05-30 Symrise Ag An active composition comprising retinol
WO2024156331A1 (en) 2023-01-23 2024-08-02 Symrise Ag A fragrance composition
WO2024199669A1 (en) 2023-03-31 2024-10-03 Symrise Ag Preparations comprising hydroxy pinacolone retinoate
EP4464309A1 (en) 2023-05-16 2024-11-20 Analyticon Discovery GmbH Antidandruff composition comprising 1-acetoxychavicol acetate
WO2025040241A1 (en) 2023-08-18 2025-02-27 Symrise Ag A sunscreen composition
WO2025051340A1 (en) 2023-09-04 2025-03-13 Symrise Ag Trpm8 modulators and related method for modulating trpm8 receptors

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287899A1 (en) * 1974-10-15 1976-05-14 Oreal NEW ENZYME-BASED COSMETIC COMPOSITIONS
US4349536A (en) * 1980-03-11 1982-09-14 Hausler Kenneth J Method of promoting suntan using a cream containing zinc and copper salts
EP0155344A2 (en) * 1983-08-02 1985-09-25 Blendax GmbH Skin treatment composition
US4806344A (en) * 1987-01-05 1989-02-21 Gaskin Frances C Sun protectant composition and method
JPH02108612A (en) * 1988-10-19 1990-04-20 Shizen:Kk Divalent and trivalent complex iron salt-compounded cosmetic
EP0380335A2 (en) * 1989-01-27 1990-08-01 Lancaster Societe Anonyme Monegasque Sun tan accelerator compositions
EP0424033A2 (en) * 1989-10-19 1991-04-24 Pola Chemical Industries Inc External skin preparation

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287899A1 (en) * 1974-10-15 1976-05-14 Oreal NEW ENZYME-BASED COSMETIC COMPOSITIONS
US4129644A (en) * 1974-10-15 1978-12-12 L'oreal Protecting skin and hair with cosmetic compositions containing superoxide dismutase
US4349536A (en) * 1980-03-11 1982-09-14 Hausler Kenneth J Method of promoting suntan using a cream containing zinc and copper salts
EP0155344A2 (en) * 1983-08-02 1985-09-25 Blendax GmbH Skin treatment composition
US4743442A (en) * 1983-08-02 1988-05-10 Blendax-Werke R. Schneider Gmbh & Co. Skin care composition
US4806344A (en) * 1987-01-05 1989-02-21 Gaskin Frances C Sun protectant composition and method
JPH02108612A (en) * 1988-10-19 1990-04-20 Shizen:Kk Divalent and trivalent complex iron salt-compounded cosmetic
EP0380335A2 (en) * 1989-01-27 1990-08-01 Lancaster Societe Anonyme Monegasque Sun tan accelerator compositions
EP0424033A2 (en) * 1989-10-19 1991-04-24 Pola Chemical Industries Inc External skin preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kono et al., Chemical Abstracts , 114(21):202133d, 2(1), pp. 18 26 (1990). *
Kono et al., Chemical Abstracts, 114(21):202133d, 2(1), pp. 18-26 (1990).

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839449A1 (en) * 2002-05-13 2003-11-14 Oreal Skin desquamation promoters and/or epidermal renewal stimulants, useful e.g. for combating skin aging symptoms or treating psoriasis, comprising metal complexes having hydrolytic action
EP1364641A1 (en) * 2002-05-13 2003-11-26 L'oreal Use of at least one metal complex as a desquamative agent
US20030224028A1 (en) * 2002-05-13 2003-12-04 Societe L'oreal S.A. Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal
US20070038269A1 (en) * 2003-02-26 2007-02-15 Photo Therapeutics Ltd. Therapeutic method and apparatus

Also Published As

Publication number Publication date
NZ242749A (en) 1994-12-22
GB9110651D0 (en) 1991-07-03
EP0584178B1 (en) 1996-08-28
TW201693B (en) 1993-03-11
CA2102515A1 (en) 1992-11-16
AU1793692A (en) 1992-12-30
MY108163A (en) 1996-08-30
EP0584178A1 (en) 1994-03-02
IL101873A0 (en) 1992-12-30
IL101873A (en) 1996-08-04
JPH06510274A (en) 1994-11-17
DE69213231T2 (en) 1997-02-20
ATE141785T1 (en) 1996-09-15
AU650343B2 (en) 1994-06-16
IE921558A1 (en) 1992-11-18
IE69260B1 (en) 1996-08-21
DE69213231D1 (en) 1996-10-02
WO1992020321A1 (en) 1992-11-26
ZA923560B (en) 1993-04-28
HK198396A (en) 1996-11-08
GR3021364T3 (en) 1997-01-31
ES2091467T3 (en) 1996-11-01

Similar Documents

Publication Publication Date Title
US5443819A (en) Composition and method of enhancing sun tanning
US5643559A (en) Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes
US5910311A (en) Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it
DE69031219T2 (en) STABLE COMPOSITION OF ASCORBIC ACID
Jurkiewicz et al. Ultraviolet light‐induced free radical formation in skin: an electron paramagnetic resonance study
EP1686096B1 (en) Use of antioxidants in clusters of structured water for reducing free radicals from skin.
US8303985B2 (en) Skin treatment compositions containing copper-pigment complexes
CA2414247C (en) Cosmetic composition and method comprising a hydroxamate mmpi and a triterpenoid glycoside
KR100190978B1 (en) Composition and method of treating depigmentation disorders
EP0941050B1 (en) Photoprotective lipophilic antioxidant compounds
US20060165617A1 (en) Cosmetic Composition and Method
Fischer et al. Suppression of uv-induced erythema by topical treatment with melatonin: Influence of the application time point
EP1038516A1 (en) Cosmetic composition comprising kynurenine
JPH069362A (en) Skin cosmetic
van Ham et al. The design of sunscreen preparations
JP2005350399A (en) Skin care preparation for external use comprising inorganic salt exhibiting antioxidative activity

Legal Events

Date Code Title Description
AS Assignment

Owner name: STIEFEL LABORATORIES, INC., FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WOOD, JOHN MARTIN;SCHALLREUTER, KARIN UTA;REEL/FRAME:006910/0870

Effective date: 19930926

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19990822

AS Assignment

Owner name: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERA

Free format text: FIRST LIEN PATENT SECURITY AGREEMENT;ASSIGNORS:STIEFEL LABORATORIES, INC.;CONNETICS CORPORATION;REEL/FRAME:018806/0699

Effective date: 20061228

AS Assignment

Owner name: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERA

Free format text: SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNORS:STIEFEL LABORATORIES, INC.;CONNETICS CORPORATION;REEL/FRAME:018816/0602

Effective date: 20061228

AS Assignment

Owner name: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERA

Free format text: FIRST LIEN PATENT SECURITY AGREEMENT;ASSIGNORS:STIEFEL LABORATORIES, INC.;CONNETICS CORPORATION;REEL/FRAME:018951/0380

Effective date: 20061228

AS Assignment

Owner name: DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERA

Free format text: SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNORS:STIEFEL LABORATORIES, INC.;CONNETICS CORPORATION;REEL/FRAME:018961/0012

Effective date: 20061228

AS Assignment

Owner name: CONNETICS CORPORATION, CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:DEUTSCHE BANK TRUST COMPANY AMERICAS;REEL/FRAME:021439/0259

Effective date: 20080820

Owner name: STIEFEL LABORATORIES, INC., FLORIDA

Free format text: RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:DEUTSCHE BANK TRUST COMPANY AMERICAS;REEL/FRAME:021439/0201

Effective date: 20080820

Owner name: STIEFEL LABORATORIES, INC., FLORIDA

Free format text: RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:DEUTSCHE BANK TRUST COMPANY AMERICAS;REEL/FRAME:021439/0259

Effective date: 20080820

Owner name: CONNETICS CORPORATION, CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST IN CONNECTION WITH SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:DEUTSCHE BANK TRUST COMPANY AMERICAS;REEL/FRAME:021439/0201

Effective date: 20080820

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载